Abstract
Due to their biological importance, oligosaccharides and glycoconjugates have recently gained much attention. Investigations of such compounds often require chemically synthesized oligosaccharides. In the oligosaccharide synthesis, glycosylation reaction is frequently the most important step. Recently, one-pot multi-step glycosylations have become popular using the glycosyl donors with different reactivities and a polymer-supported technology that can reduce the laborious purification operations. For such methodologies, stereoselective glycosylation is essential. Compared to the 1,2-trans-glycoside formation, highly cis-selective glycosylation has remained relatively elusive. To enhance cis-selectivity, protection of the 2-position using a benzyl type ether and solvent effects are often employed. Recent reports have described the manipulation of protecting groups to afford novel donors that allow improved cisselective glycosylation. This manuscript reviews such donors that have been reported within the last five years. We hope this manuscript proves to be helpful in furthering the chemical syntheses of oligosaccharides while improving our understanding of the glycosylation reaction including stereoelectronic effects.
Keywords: Glycosylation reaction, stereoselectivity, protecting group
Current Bioactive Compounds
Title: Optimizing Glycosylation Reaction Selectivities by Protecting Group Manipulation
Volume: 4 Issue: 4
Author(s): Shino Manabe and Yukishige Ito
Affiliation:
Keywords: Glycosylation reaction, stereoselectivity, protecting group
Abstract: Due to their biological importance, oligosaccharides and glycoconjugates have recently gained much attention. Investigations of such compounds often require chemically synthesized oligosaccharides. In the oligosaccharide synthesis, glycosylation reaction is frequently the most important step. Recently, one-pot multi-step glycosylations have become popular using the glycosyl donors with different reactivities and a polymer-supported technology that can reduce the laborious purification operations. For such methodologies, stereoselective glycosylation is essential. Compared to the 1,2-trans-glycoside formation, highly cis-selective glycosylation has remained relatively elusive. To enhance cis-selectivity, protection of the 2-position using a benzyl type ether and solvent effects are often employed. Recent reports have described the manipulation of protecting groups to afford novel donors that allow improved cisselective glycosylation. This manuscript reviews such donors that have been reported within the last five years. We hope this manuscript proves to be helpful in furthering the chemical syntheses of oligosaccharides while improving our understanding of the glycosylation reaction including stereoelectronic effects.
Export Options
About this article
Cite this article as:
Manabe Shino and Ito Yukishige, Optimizing Glycosylation Reaction Selectivities by Protecting Group Manipulation, Current Bioactive Compounds 2008; 4 (4) . https://dx.doi.org/10.2174/157340708786847861
DOI https://dx.doi.org/10.2174/157340708786847861 |
Print ISSN 1573-4072 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6646 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
The Malarial Drug Target Plasmodium falciparum 1-Deoxy-D-Xylulose-5- Phosphate Reductoisomerase (PfDXR): Development of a 3-D Model for Identification of Novel, Structural and Functional Features and for Inhibitor Screening (Supplementary Information)
Protein & Peptide Letters Pulmonary Sarcoidosis Presenting with Miliary Opacities
Current Medical Imaging Vaccine Development for Potential Bioterrorism Agents
Current Drug Targets - Infectious Disorders Structural Genomics and Drug Discovery for Infectious Diseases
Infectious Disorders - Drug Targets Chagas Disease: Progress and New Perspectives
Current Medicinal Chemistry The Druggable Antimalarial Target PfDXR: Overproduction Strategies and Kinetic Characterization
Protein & Peptide Letters Analysis of Molecular Targets of Mycobacterium tuberculosis by Analytical Ultracentrifugation
Current Medicinal Chemistry Microbial Biotransformation: Recent Developments on Steroid Drugs
Recent Patents on Biotechnology Hepatotoxicity of Antiretroviral Drugs
Current Pharmaceutical Design Latent Tuberculosis: Is There a Role for Thioridazine?
Recent Patents on Anti-Infective Drug Discovery Pathogen Interactions with DC-SIGN Modulate Immune Responses: A Toll Tale?
Current Immunology Reviews (Discontinued) A Brief Review of the Essential Role of Nanovehicles for Improving the Therapeutic Efficacy of Pharmacological Agents Against Tumours
Current Drug Delivery <i>Prunella vulgaris</i> L: Critical Pharmacological, Expository Traditional Uses and Extensive Phytochemistry: A Review
Current Drug Discovery Technologies Burkholderia mallei and Burkholderia pseudomallei: The Causative Micro-organisms of Glanders and Melioidosis
Recent Patents on Anti-Infective Drug Discovery Microbial Cold Shock Proteins: Overview of their Function and Mechanism of Action
Protein & Peptide Letters State of the Art Review and Report of New Tool for Drug Discovery
Current Topics in Medicinal Chemistry In vitro and In silico Analysis of β-lactam Derivatives as Antimycobacterial Agents
Letters in Drug Design & Discovery A Compendium of Volatile Organic Compounds (VOCs) Released By Human Cell Lines
Current Medicinal Chemistry The α/β Hydrolase Fold Proteins of Mycobacterium tuberculosis, with Reference to their Contribution to Virulence
Current Protein & Peptide Science Recent Achievements on Siderophore Production and Application
Recent Patents on Biotechnology